Company / Financials
IMMUCELL CORP /DE/ Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$26.5M
FY2025 · +51.6% YoY
Net Income
-$2.2M
FY2025 · +62.7% YoY
Profit Margin
-8.1%
FY2025 · net income / revenue
ROE
-7.8%
FY2025 · return on equity
Total Assets
$42.5M
FY2025
Total Debt
$7.5M
0.27x debt/equity
Equity
$27.5M
FY2025
ROA
-5.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$26.5M+51.6% YoYNet Income HistoryProfit after all expenses and taxes-$2.2M+62.7% YoYGross Profit HistoryRevenue minus cost of goods sold$7.9M+105.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$18.6M+36.4% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$1.6M+71.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$2.2M+3.9% YoYR&D Expense HistoryResearch and development spending$3.9M-11.3% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$10.1K+117.3% YoYEPS (Basic) HistoryBasic earnings per share-$0.26+65.3% YoY